CDD-2807
CDD-2807 is an inhibitor for serine/threonine kinase 33 (STK33) with IC50 of 9.2 nM. CDD-2807 exhibits no significant toxicity in mice and can cross the blood-testis barrier without accumulating in the brain. CDD-2807 induces a reversible contraceptive effect and has potential for the development of the male contraceptive[1].
Product Specifications
CAS Number
3086536-23-1
UNSPSC
12352005
Target
CDK; RET; STK33
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Protein Tyrosine Kinase/RTK
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/cdd-2807.html
Purity
99.52
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(C1=CC2=C(NN=C2C#CC3=CC=CC=C3C4=CC=CC=C4)C=C1)N5CC6(CNCCC6)C5
Molecular Formula
C29H26N4O
Molecular Weight
446.54
References & Citations
[1]Ku AF, et al., Reversible male contraception by targeted inhibition of serine/threonine kinase 33. Science. 2024 May 24;384 (6698) :885-890.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CLK
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Alkaline Phosphatase Conjugated Urtica Dioica Lectin (Stinging Nettle) -UDA-
(5Alpha,6Alpha)-Epoxy-17Alpha-hydroxy-pregnane-3,20-dione 20-Bis(ethyleneketal)
BRUNOL4 (CELF4) (NM_001025087) Human Over-expression Lysate
CD31 / PECAM-1 (Endothelial Cell Marker) (PECAM1/3540), CF568 conjugate, 0.1mg/mL
